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  Streptococcus  agalactiae  is  a  major  contagious  pathogen  causing  bovine  sub-clinical 
mastitis.  The  present  investigation  was  carried  out  to  determine  some  phenotypic 
characteristics of the S. agalactiae strains isolated from bovine mastitis cases in dairy cows of 
Shahrekord  in  the  west-center  of  Iran.  One  hundred  eighty  California  mastitis  test  (CMT) 
positive milk samples were bacteriologically studied. A total of 31 (17.2%) S. agalactiae isolated. 
Twenty eight (90.3%) of the isolates were biofilm producers. This finding may indicate the high 
potential  of  pathogenicity  in  isolated  strains.  Sixteen  (51.6%)  isolates  were  α  hemolysin 
producers.  Only  19.3%,  22.5%  and  29.0%  of  the  isolates  were  sensitive  to  streptomycin, 
flumequine  and  kanamycin,  respectively.  None  of  these  three  agents  is  recommended  for 
treatment of mastitis cases.  
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 ׌بور֩׌م دض داوم هب ت׌ساسح و ن׌ز׌لومه د׌لوت ،مل׌فو׌ب ل׌֩شت ه׌ت֩لااگآ سو֩و֩وتپرتسا    هقطنم رد ناتسپ مرو هب لاتبم ׌اه واگ ر׌ش زا هدش ادج ر׌ا ،در֩رهش نا  
 
 هد׌֩چ  
سو֩و֩وتپرتسا   ه׌ت֩لاا֯آ   ن֘وتاپ   ׌لصا   و   ׌رسم   داج׌ا   هدنن֩   مرو   ناتسپ   تحت   ׌ها֯نامرد   وا֯   ׌م   دشاب  . هعلاطم   رضاح   هب   روظنم   ن׌׌عت   ׌خرب   تا׌صوصخ   ֩׌پ׌تونف   ه׌ادج   ׌اه   تسدب   هدمآ   ن׌ا  
׌رت֩اب   زا   دراوم   مرو   ناتسپ   تحت   ׌ها֯نامرد   ׌اهوا֯   ׌ر׌ش   رد   در֩رهش   عقاو   رد   ز֩رم   ׌برغ   ا نار׌   ماجنا   هدش   تسا  . دص֩׌   و   داتشه   هنومن   ر׌ش    هج׌تن اب تبثم   ،ناتسپ مرو نومزآ   دروم   هعلاطم  
֩׌֘ولو׌رت֩اب   رارق   تفر֯  . رد   عومجم   13   ( 2 / 31   دصرد  ) ه׌ادج   سو֩و֩وتپرتسا   ه׌ت֩لاا֯آ   تسدب   دمآ  . تس׌ب   و   تشه   ه׌ادج   ( 1 / 09   دصرد  ) د׌لوت   مل׌فو׌ب   دندومن  . ن׌ا   هتفا׌   ن֩مم   تسا   ر֯نا׌ب  
׌رام׌ب   ׌׌از   هوقلاب   ׌لااب   ه׌ادج   اه   دشاب  . هدزناش   ه׌ادج   ( 6 / 13   دصرد  ) ن׌ز׌لومه   افلآ   د׌لوت   دندومن  . اهنت   1 / 30 ،   1 / 22   و   9 / 20   دصرد   ه׌ادج   اه   ب׌ترتب   هب   ،ن׌س׌اموتپرتسا   ن׌ئو֩مولف   و   ن׌س׌امانا֩   ساسح  
دندوب  . ماد֩چ׌ه   زا   ن׌ا   هس   وراد   تهج   نامرد   دراوم   مرو   ناتسپ   ت ه׌صو   ׌من   دنوش .  
اه ه֘او :׌د׌ل֩ ׌   سو֩و֩وتپرتسا ،   ،نار׌ا   ،مل׌فو׌ب   ت׌ساسح   هب   داوم   دض   ،׌بور֩׌م   مرو   ناتسپ  
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Introduction 
 
Streptococcus agalactiae is a highly contagious, obligate 
bacterium of the bovine mammary gland. This bacterium 
can survive a very short time in the environment, but it 
can persist indefinitely within the mammary gland as an 
obligate pathogen of the udder.1 
The routine method for detection of S. agalactiae in 
milk  samples  is  bacteriological  culture.  S.  agalactiae  is 
identified  in  the  veterinary  laboratory  by  Christie, 
Atkins, Munch, Petersentest (CAMP) factor, hydrolysis of 
hippurate and lack of hydrolysis of esculin. Carbohydrates 
fermentation is also used for confirming differentiation of 
S. agalactiae from other streptococci isolated from bovine 
mammary glands.2 
The  type  of  hemolysis  produced  by  streptococcal 
species  can  be  variable;  β  hemolysis  defined  as  a  clear 
zone of hemolysis around the colony, α hemolysis causes 
zone  of  greening  or  partial  hemolysis  and  γ  causes  no 
visible hemolysis. Generally the β - hemolytic streptococci 
tend to be the most pathogenic for animals.2 
The biofilms is consisted of micro colonies encased in 
extracellular  polysaccharide  material.  Bacteria  inside 
biofilms have increased resistance to antimicrobial agents. 
The  production  of  biofilms  was  correlated  with  patho-
genicity and virulence of bacteria.3 
Many common bacterial pathogens exist in animals as 
biofilms.  Mastitis  is  a  typical  animal  disease  where 
bacterial  biofilms  are  believed  to  be  involved  based  on 
histopathologic  and  ultra-structural  appearance  of  the 
bacteria within tissue.4 
To treat clinical mastitis successfully and to implement 
dry cow therapy efficiently, one should know the prevalence 
and  the  antimicrobial  susceptibility  of  microorganisms 
isolated  from  the  mammary  gland.  The  susceptibility  of 
bacteria  in  various  geographical  locations  may  change 
with time due to selective pressure of antimicrobial therapy.  
The  present  study  was  undertaken  in  order  to 
determine some phenotypic characteristics of S. agalactiae 
isolates from bovine mastitis in Shahrekord district in the 
west centre of Iran.  
 
Materials and Methods 
 
Sample  collection.  The  study  covered  a  10-month 
period  from March to December  2011. Mastitis affected 
cows were identified by CMT (2+ or more).5 After pre-milk 
hand-stripping, teat orifices were scrubbed with a cotton 
pledged saturated in 70% ethyl alcohol. 
CMT positive milk samples were aseptically collected 
from different dairy farms in Shahrekord district. The ice 
box  containing  milk  samples  in  tubes  were  sent  to  the 
microbiology laboratory of veterinary school (Shahrekord 
University,  Shahrekord,  Iran)  for  isolation  of  strains.  In 
total 180 CMT positive milk samples were collected. 
 
  Isolation of S. agalactiae. On arrival at the laboratory, 
0.1  mL  of  milk  were  streaked  onto  thallium  sulphate-
crystal  violet-B  toxin  blood  agar  (TKT  agar;  Merck, 
Darmstadt,  Germany)  medium  containing  7%  sheep 
blood, and incubated aerobically at 37 ˚C for 24-72 hr. 
Colonies  with  morphology  matched  to  those  of 
streptococci  colonies,2  on  each  cultured  plate  were 
selected  for  further  examinations.  Colonies  yielding 
gram-positive  cocci  with  catalase-negative  and  oxidase 
negative  reaction  were  pure  cultured  on  sheep  blood 
agar plates (Merck, Darmstadt, Germany), Hemolysis was 
scored and then subjected to CAMP test on sheep blood 
agar and esculin hydrolysis on TKT tests. Rapid hippurate 
hydrolysis  test  was  conducted  as  described  by  Marcia 
and Grace.6 The growth of isolates on MacConkey agar 
(Merck, Darmstadt, Germany) were also examined.  
Carbohydrate utilization was conducted in phenol red 
broth (PRB; BBL Microbiology Systems, Cockeysville, USA) 
with  1%  final  concentration  of  the  following  carbo-
hydrates: lactose, maltose, mannitol, raffinose, salicin and 
trehalose. Positive reactions were indicated by a change 
from red to yellow after aerobic incubation at 37 ˚C for 24 
hr.  Identification  of  S.  agalactiae  was  performed  as 
described by Quinn et al.2 
Biofilm  assay.  The  biofilm  assay  was  performed  by 
using micro titer plates as described by Tendolkar et al.7 
Flat-bottom  micro  titer  plates  were  used.  S.  agalactiae 
isolates were grown at 37 ˚C in tryptic soy broth (TSB; 
Merck, Darmstadt, Germany). The bacterial cells were then 
pelleted  at  6,000  g  for  10  min,  and  the  cell  pellet  re-
suspended in 5 mL of fresh medium. The optical densities 
(ODs) of the bacterial suspensions were measured using 
spectrophotometer (Model 6305, Jenway Ltd., Essex, UK) 
and normalized to an absorbance of 1.00 at 595 nm. The 
cultures were diluted 1:40 in fresh TSB and 200 μL of cells 
were dispensed into 12 wells in a single row of a sterile 
96-well flat-bottom polystyrene micro titer plate.  
After incubation at 37 ˚C for 24 hr, the planktonic cells 
were  aspirated  and  the  wells  washed  three  times  with 
sterile phosphate-buffered saline (PBS). The plates were 
inverted and allowed to dry for 1 hr at room temperature. 
For biofilms quantification, 200 μL of 0.2% aqueous crystal 
violet solution was added to each well, and the plates were 
allowed to stand for 15 min. The wells were subsequently 
washed three times with sterile PBS to wash off the excess 
crystal  violet.  Crystal  violet  bound  to  the  biofilms  was 
extracted with 200 μL of an 80:20 (v/v) mixture of ethyl 
alcohol and acetone, and the absorbance of the extracted 
crystal violet was measured at 595 nm. 
As  a  control,  crystal  violet  binding  to  wells  was 
measured for wells exposed only to the medium with no 
bacteria. All biofilm assays were performed in triplicate, 
with 12 replicates for each strain per assay. 
Interpretation of biofilm production was according to 
the criteria described by Stepanovic et al.8 Based on these 271 
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criteria optical density cut-off value (ODc) was defined as: 
average OD of negative control + 3 × SD (standard deviation) 
of  negative  control,  and  the  biofilms  producers  are 
categorized as: no biofilm producer ≤ ODc, weak biofilm 
producer ODc < ~ ≤ 2 × ODc, moderate biofilm producer 
2 × ODc < ~ ≤ 4 × ODc and strong biofilm producer > 4 × ODc; 
where "~ " stands for average of sample ODs. 
Susceptibility testing. For susceptibility testing, isolates 
were incubated in trypticase soy broth at 37 ˚C for 24 hr 
and the suspension was adjusted to a turbidity equivalent 
to a 0.5 McFarland standard. Susceptibility to antimicrobial 
agents  was  determined  for  isolated  strains  by  the  disk 
diffusion method on Mueller-Hinton agar (Merck, Darmstadt, 
Germany), containing 3-5% ovine serum, according to the 
National  Committee  for  Clinical  Laboratory  Standards 
guidelines.9 The selected antibiotics for antibiogram were 
those that were more common in treatment of regional 
bovine mastitis cases as appeared in Table 1. 
Isolates were categorized as susceptible and resistant 
based upon interpretive criteria developed by the National 
Committee of Clinical Laboratory Standards.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
Out of the 180 CMT positive milk samples studied for S. 
agalactiae  infection,  the  bacteria  was  isolated  from  31 
(17.2%) of the milk samples. Twenty eight (90.3%) of the 
isolates were biofilm producers, among them 6 (19.3%), 
14 (45.1%) and 8 (25.8%) isolates were strong, moderate 
and weak biofilm producers, respectively. 
Sixteen (51.6%) isolates were α-hemolysin producers 
while  we  did  not  detect  any  β  hemolysin  one.  Fifteen 
isolates  (93.7%)  of  α  hemolysin  producer  were  biofilm 
producers simultaneously. 
The  sensitivity  of  the  S.  agalactiae  isolates  to  anti-
microbial  compounds  is  given  in  Table  1.  Overall,  only 
19.3%, 22.5% and 29.0% of the isolates were sensitive to 
streptomycin, flumequine and kanamycin, respectively. 
  Discussion 
 
In  this  study  31  (17.2%)  isolates  from  180  CMT 
positive milk samples were identified as S. agalactiae. This 
finding  indicates  that  the  prevalence  of  S.  agalactiae  in 
infected cows in Shahrekord district is almost the same as 
other regions of our country.11  
Sixteen  (51.6%)  of  our  isolates  were  α  hemolysin 
producers, whose 15 (93.7%) were also biofilm producers. 
Nicky  and  O’Toole  showed  a  role  for  α  hemolysin  in  S. 
aureus biofilm formation and that this toxin appears to be 
required for cell-to-cell interactions.12 This role may also 
be involved in S. agalactiae but we could not find similar 
reports in this regard. 
We did not detect any β hemolysin producer isolates. 
In  bovine  strains  of  S.  agalactiae  the  type  of  hemolysis 
produced can be variable but in human isolates it seems 
that production  of β hemolysin is a constant feature.2,13 
Twenty eight (90.3%) of our isolates were biofilm producers. 
The  production  of  biofilms  was  correlated  with  patho-
genicity and virulence of bacteria.3 Microorganisms inside 
biofilms have increased resistance to antimicrobial agents.3 
Thus, our finding may indicate the high potential of patho-
genicity  in  isolated  strains.  We  could  not  find  reports 
regarding the prevalence of biofilm formation among the 
strains of S. agalactiae, but it is documented that it has the 
potential of producing this virulence factor.4 Comparing to 
other streptococci, Petersson-Wolfe et al. reported a low 
frequency of biofilm formation by E. fecalis isolates.14 They 
concluded that biofilm formation by this species did not 
seem to be a prerequisite for colonization of the bovine 
mammary gland. In  other hand,  biofilm formation  by  S. 
pyogenes is reported to be an important virulence factor.15 
The ability of S. agalactiae to produce slime might be a 
desirable virulence factor during colonization of the udder. 
It  has  been  shown  that  slime  production  is  important, 
allowing some bacteria to aggregate and form biofilms.16 
The antimicrobial susceptibility data for isolates of S. 
agalactiae are summarized in Table 1. Results of this study 
demonstrated low sensitivity for streptomycin, flumequine 
and  kanamycin.  These  agents  are  used  to  treat  mastitis 
cases  and  other  diseases  in  cattle.  None  of  these  three 
agents is recommended for treatment of mastitis cases due 
to their limited activity against the examined organisms.  
Some authors documented resistance to streptomycin, 
kanamycin and sensitivity to β-lactam drugs in Streptococcus 
species isolated from clinical mastitis in dairy cows,17 our 
results are in line with these findings.  
In  summary,  the  majority  of  S.  agalactiae  isolates 
(90.3%) evaluated in this study formed biofilms under in 
vitro  conditions.  Further  work  to  assess  S.  agalactiae 
ability  to  form  biofilms  in  vivo  and  intra  mammary 
infection is suggested. This will allow for development of 
new strategies to a better management and prevention of 
mastitis caused by this pathogen. The isolates also showed 
Table 1. Antibiotic susceptibility responses of S. agalactiae strains 
isolated from CMT positive bovine milk samples. 
Antibiotics 
Susceptibility 
Sensitive 
(%) 
Intermediate 
sensitive (%) 
Non-sensitive 
  (%) 
Amoxicillin 
Kanamycin 
Ampicillin 
Enrofloxacin 
Penicillin 
Ciprofloxacin 
Trimetoprime 
Tetracycline 
Gentamicin 
Flumequine 
Erythromycin 
Streptomycin 
30 (96.7) 
09 (29.0) 
30 (96.7) 
19 (61.2) 
23 (74.1) 
28 (90.3) 
25 (80.6) 
27 (87.0) 
23 (74.1) 
07 (22.5) 
19 (61.2) 
06 (19.3) 
00.0 (0)000) 
05 (16.1) 
00.0 (0)000) 
12 (38.7) 
2 (6.4) 
3 (9.6) 
1 (3.2) 
1 (3.2) 
3 (9.6) 
.0 (0)0) 
2 (6.4) 
07 (22.5) 
1 (3.2) 
17 (54.8) 
1 (3.2) 
.0 (0)0) 
06 (19.3) 
0 (0)… 
...5 (16.1) 
3 (9.6)  
05 (16.1) 
24 (77.4) 
10 (32.2) 
18 (58.0) 
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low sensitivity to streptomycin, flumequine and kanamycin. 
More vigilant policies on the use of antibiotics in animals 
may limit distribution of resistance genes between bacteria 
and result in an improvement of the current situation.  
 
References  
 
1.  Kefee GP. Streptococcus agalactiae mastitis: A review. 
Can Vet J 1997; 38(7): 429-437. 
2.  Quinn  PJ,  ME  Carter,  BK  Markey,  et  al.  Clinical 
veterinary  microbiology.  1st  ed.  London,  UK:  Mosby 
1994; 130-136. 
3.  Saginur  R,  St.  Denis  M,  Ferris  W,  et  al.  Multiple 
combination  bactericidal  testing  of  staphylococcal 
biofilms  from  implant-associated  infections.  Antimicrob 
Agents Chemother 2006; 50(1): 55-61. 
4.  Costerton  JW,  Stewart  PS,  Greenberg  EP.  Bacterial 
biofilms:  A  common  cause  of  persistent  infections. 
Science 1999; 284: 1318-1322. 
5.  Esron DK, Lughano JK, Robinson HM, et al. Studies on 
mastitis, milk quality and health risks associated with 
consumption of milk from pastoral herds in Dodoma 
and Morogoro regions, Tanzania. J Vet Sci 2005; 6(3): 
213-221. 
6.  Marcia  R,  Lee  M,  Grace  MD.  Evaluation  of  the  rapid 
hippurate  hydrolysis  test  with  enterococcal  group  D 
streptococci. J Clin Microbiol 1977; 5(3): 290-292. 
7.  Tendolkar  PM,  Baghdayan  AS,  Gilmore  MS,  et  al. 
Enterococcal surface protein enhances biofilm formation 
by  Enterococcus  fecalis.  Infect  Immun  2004;  72(10): 
6032-6039.  
8.  Stepanovi S, Vukovi D, Hola V, et al. Quantification of bio-
film in microtiter plates: Overview of testing conditions 
and  practical  recommendations  for  assessment  of 
biofilm  production  by  staphylococci.  Acta  Pathol 
Microbiol Immunol Scand 2007; 115(8): 891-899. 
  9.  National  committee  for  clinical  laboratory 
standards. Performance standards for antimicrobial 
disk  and  dilution  susceptibility  tests  for  bacteria 
isolated  from  animals.  Wayne,  USA:  National 
Committee for Clinical Laboratory Standards 2002; 
Approved standard M31-A2. 
10. National committee  for clinical laboratory standards. 
Performance standards for antimicrobial susceptibility 
testing:  9th  informational  supplement.  Wayne,  USA: 
National Committee for Clinical Laboratory Standards 
1999; Approved standard M100-S9. 
11. Atyabi N, Vodjgani M, Gharagozloo F, et al. Prevalence 
of  bacterial mastitis in cattle from the  farms around 
Tehran. Iran J Vet Res 2006; 7(3): 76-79. 
12. Nicky  CC,  O’Toole  GA.  Alpha-toxin  is  required  for 
biofilm formation by Staphylococcus aureus. J Bacteriol 
2003; 185(10): 3214-3217. 
13. Mosabi  JM,  Arimi  SM,  Kang'ethe  EK.  Isolation  and 
characterization of group B streptococci from human 
and  bovine  sources  within  and  around  Nairobi. 
Epidemiol Infect 1997; 118(3): 215-220. 
14. Petersson-Wolfe CS, Wolf SL, Hogan JS. In vitro growth 
of  enterococci  of  bovine  origin  in  bovine  mammary 
secretions from various stages of lactation. J Dairy Sci 
2007; 90: 4226-4231. 
15. Conley J, Olson ME, Cook LS, et al. Biofilm formation by 
group A streptococci: Is there a relationship with treat-
ment failure? J Clin Microbiol 2003; 41(9): 4043-4048. 
16. Arciola CR, Campoccia D, Montanaro L. Detection of 
biofilms-forming  strains  of  Staphylococcus  epi-
dermidis and S. aureus. Expert Rev Mol Diagn 2002; 
2(5): 478-484. 
17. Guérin-Faublée  V,  Tardy  F,  Bouveron  C,  et  al.  Anti-
microbial susceptibility of Streptococcus species isolated 
from clinical mastitis in dairy cows. Int J Antimicrob 
Agents 2002; 19(3): 219-226. 